Dr. Katja Vu Bartholdy and Dr. Gibson discuss: Effects Of Dapagliflozin On Echocardiographic Measures Of Cardiac Structure And Function In Patients With Chronic Kidney Disease: The DECODE-CKD Trial March 31, 2025 Disclosures: TBD
Dr. Matthew J. Budoff and I discuss: Effect Of Colchicine On Progression Of Known Coronary Atherosclerosis In Patients With Stable Coronary Artery Disease Compared To Placebo Ekstrom Trial March 31, 2025 Disclosures: TBD
Dr. Saibal Kar and I discuss: Two-year Outcomes Of Transcatheter Tricuspid Valve Edge-to-edge Repair For Tricuspid Regurgitation: The Triluminate Pivotal Trial March 30, 2025 Disclosures: TBD
Dr. Carolyn Hendrickson and I discuss: The Equiox Study: Evaluating Pulse Oximeter Bias Across A Range Of Skin Pigment In Critically Ill Adults March 30, 2025 Disclosures: TBD
Dr. Steven E. Nissen and I discuss: An Extended Duration Small-interfering RNA Targeting Lipoprotein(a): The Alpaca Phase 2 Trial Of Lepodisiran With 540 Day Follow Up March 30, 2025 Disclosures: TBD
Dr. Pavel Osmancik and I discuss: Catheter Ablation Vs. Risk Factor Modification With Antiarrhythmic Drugs To Treat Atrial Fibrillation – PRAGUE-25 Study March 30, 2025 Disclosures: TBD
Dr. Giulia Magnani and I discuss: Alliance For Secondary Prevention After An Acute Coronary Syndrome. March 30, 2025 Disclosures: TBD
Dr. Joo- Yong Hahn and I discuss: Clopidogrel Versus Aspirin For Long-term Maintenance Monotherapy In Patients With High Ischemic Risk After Percutaneous Coronary Intervention March 30, 2025 Disclosures: TBD
Dr. William F. Fearon and I discuss: Fractional Flow Reserve Guided Percutaneous Coronary Intervention Compared With Bypass Surgery: Final 5 Year Results Of The Fractional Flow Reserve Versus Angiography For Multivessel Evaluation 3 Trial March 30, 2025 Disclosures: TBD
Dr. Saibal Kar and I discuss: Two-year Outcomes Of Transcatheter Tricuspid Valve Edge-to-edge Repair For Tricuspid Regurgitation: The Triluminate Pivotal Trial March 30, 2025 Disclosures: TBD
